BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jomrich G, Paireder M, Gleiss A, Kristo I, Harpain L, Schoppmann SF. Comparison of Inflammation-Based Prognostic Scores in a Cohort of Patients with Resectable Esophageal Cancer. Gastroenterol Res Pract 2017;2017:1678584. [PMID: 28740506 DOI: 10.1155/2017/1678584] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Yang Q, Shen A, Chen X, Guo L, Peng H, Gao M. Clinical Significance of Nutrition and Inflammation in Esophageal Cancer Patients with Surgery: A Meta-Analysis. Nutr Cancer 2022;:1-12. [PMID: 35341393 DOI: 10.1080/01635581.2022.2056620] [Reference Citation Analysis]
2 Zhang Y, Xiao G, Wang R. Clinical significance of systemic immune-inflammation index (SII) and C-reactive protein-to-albumin ratio (CAR) in patients with esophageal cancer: a meta-analysis. Cancer Manag Res 2019;11:4185-200. [PMID: 31190988 DOI: 10.2147/CMAR.S190006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
3 Wang Y, Hu X, Huang Y, Xu WY, Wu YM, Li PF, Che GW. Prognostic value of the C-reactive protein to albumin ratio in esophageal cancer: A systematic review and meta-analysis. Kaohsiung J Med Sci 2020;36:54-61. [PMID: 31512813 DOI: 10.1002/kjm2.12129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sakai M, Sohda M, Saito H, Ubukata Y, Nakazawa N, Kuriyama K, Hara K, Sano A, Ogata K, Yokobori T, Shirabe K, Saeki H. Comparative Analysis of Immunoinflammatory and Nutritional Measures in Surgically Resected Esophageal Cancer: A Single-center Retrospective Study. In Vivo 2020;34:881-7. [PMID: 32111799 DOI: 10.21873/invivo.11853] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Jomrich G, Hollenstein M, John M, Baierl A, Paireder M, Kristo I, Ilhan-Mutlu A, Asari R, Preusser M, Schoppmann SF. The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction. Oncotarget 2018;9:6968-76. [PMID: 29467943 DOI: 10.18632/oncotarget.24087] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
6 Zhou T, Zhao Y, Zhao S, Yang Y, Huang Y, Hou X, Zhao H, Zhang L. Comparison of the Prognostic Value of Systemic Inflammation Response Markers in Small Cell Lung Cancer Patients. J Cancer 2019;10:1685-92. [PMID: 31205524 DOI: 10.7150/jca.29319] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
7 Li Y, Luan C. PLCE1 Promotes the Invasion and Migration of Esophageal Cancer Cells by Up-Regulating the PKCα/NF-κB Pathway. Yonsei Med J 2018;59:1159-65. [PMID: 30450849 DOI: 10.3349/ymj.2018.59.10.1159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Yu X, Wen Y, Lin Y, Zhang X, Chen Y, Wang W, Wang G, Zhang L. The value of preoperative Glasgow Prognostic Score and the C-Reactive Protein to Albumin Ratio as prognostic factors for long-term survival in pathological T1N0 esophageal squamous cell carcinoma. J Cancer 2018;9:807-15. [PMID: 29581759 DOI: 10.7150/jca.22755] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
9 Lorton CM, Higgins L, O'Donoghue N, Donohoe C, O'Connell J, Mockler D, Reynolds JV, Walsh D, Lysaght J. C-Reactive Protein and C-Reactive Protein-Based Scores to Predict Survival in Esophageal and Junctional Adenocarcinoma: Systematic Review and Meta-Analysis. Ann Surg Oncol 2021. [PMID: 34773194 DOI: 10.1245/s10434-021-10988-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Jomrich G, Gruber ES, Winkler D, Hollenstein M, Gnant M, Sahora K, Schindl M. Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection. J Gastrointest Surg. 2020;24:610-618. [PMID: 30923999 DOI: 10.1007/s11605-019-04187-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 10.7] [Reference Citation Analysis]
11 Wang Y, Li P, Li J, Lai Y, Zhou K, Wang X, Che G. The prognostic value of pretreatment Glasgow Prognostic Score in patients with esophageal cancer: a meta-analysis. Cancer Manag Res 2019;11:8181-90. [PMID: 31564977 DOI: 10.2147/CMAR.S203425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
12 Jomrich G, Paireder M, Kristo I, Baierl A, Ilhan-Mutlu A, Preusser M, Asari R, Schoppmann SF. High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma. Ann Surg 2021;273:532-41. [PMID: 31425286 DOI: 10.1097/SLA.0000000000003370] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 16.0] [Reference Citation Analysis]
13 Takeuchi M, Hoshino S, Kawakubo H, Matsuda S, Mayanagi S, Irino T, Fukuda K, Nakamura R, Wada N, Kitagawa Y. Author Reflections: Relationship of Systemic Inflammatory Response Indicators at Recurrence to Long-Term Outcomes in Patients with Recurrent Esophageal Squamous Cell Carcinoma: The Utility of Neutrophil-to-Lymphocyte Ratio. Ann Surg Oncol 2021;28:3009-10. [PMID: 33651215 DOI: 10.1245/s10434-021-09638-z] [Reference Citation Analysis]
14 Zhao C, Ding C, Xie T, Zhang T, Dai X, Wei Y, Li Y, Gong J, Zhu W. Validation and optimization of the Systemic Inflammation-Based modified Glasgow Prognostic Score in predicting postoperative outcome of inflammatory bowel disease: preliminary data. Sci Rep 2018;8:747. [PMID: 29335491 DOI: 10.1038/s41598-017-18771-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]